ID

42142

Beschreibung

A Study of ARQ 197 in Combination With Erlotinib; ODM derived from: https://clinicaltrials.gov/show/NCT01251796

Link

https://clinicaltrials.gov/show/NCT01251796

Stichworte

  1. 29.05.16 29.05.16 -
  2. 13.04.21 13.04.21 - Dr. rer. medic Philipp Neuhaus
Hochgeladen am

13. April 2021

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Advanced/Recurrent Non-small-cell Lung Cancer NCT01251796

Eligibility Advanced/Recurrent Non-small-cell Lung Cancer NCT01251796

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
voluntary written informed consent for study participation must be obtained
Beschreibung

informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
a histologically or cytologically confirmed advanced/recurrent non-small-cell lung cancer
Beschreibung

non-small-cell lung cancer

Datentyp

boolean

Alias
UMLS CUI [1]
C0007131
history of ≥1 prior chemotherapy regimen (treatment with egfr tyrosine kinase inhibitors will be counted as one regimen)
Beschreibung

chemotherapy regimen

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1443775
ecog ps of 0 or 1
Beschreibung

ecog

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy of ≥3 months
Beschreibung

life expectancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0023671
poor metabolizers as defined by cyp2c19 genotype
Beschreibung

CYP2 gene

Datentyp

boolean

Alias
UMLS CUI [1]
C1332828
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
anti-cancer chemotherapy, anti-cancer therapy with egfr-tki, hormone therapy, radiotherapy, immunotherapy, other investigational agents or anti-cancer antibody therapy within 28 days prior to arq 197 dose
Beschreibung

egfr-tki

Datentyp

boolean

surgery for cancer within 28 days prior to arq 197 dose
Beschreibung

cancer surgery

Datentyp

boolean

Alias
UMLS CUI [1]
C0920424
active double cancer
Beschreibung

Multiple malignancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0346429
known symptomatic brain metastases
Beschreibung

brain metastases

Datentyp

boolean

Alias
UMLS CUI [1]
C0220650
an intercurrent illness that is uncontrolled (e.g., infection, symptomatic congestive heart failure, unstable angina pectoris, symptomatic arrhythmia, interstitial pneumonia)
Beschreibung

intercurrent illness

Datentyp

boolean

Alias
UMLS CUI [1]
C3640977
pregnant or lactating
Beschreibung

pregnant or lactating

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
subjects who wish to have a child and who would not agree to use contraceptive measures
Beschreibung

contraceptive measures

Datentyp

boolean

Alias
UMLS CUI [1]
C0700589

Ähnliche Modelle

Eligibility Advanced/Recurrent Non-small-cell Lung Cancer NCT01251796

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
informed consent
Item
voluntary written informed consent for study participation must be obtained
boolean
C0021430 (UMLS CUI [1])
non-small-cell lung cancer
Item
a histologically or cytologically confirmed advanced/recurrent non-small-cell lung cancer
boolean
C0007131 (UMLS CUI [1])
chemotherapy regimen
Item
history of ≥1 prior chemotherapy regimen (treatment with egfr tyrosine kinase inhibitors will be counted as one regimen)
boolean
C0392920 (UMLS CUI [1,1])
C1443775 (UMLS CUI [1,2])
ecog
Item
ecog ps of 0 or 1
boolean
C1520224 (UMLS CUI [1])
life expectancy
Item
life expectancy of ≥3 months
boolean
C0023671 (UMLS CUI [1])
CYP2 gene
Item
poor metabolizers as defined by cyp2c19 genotype
boolean
C1332828 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
egfr-tki
Item
anti-cancer chemotherapy, anti-cancer therapy with egfr-tki, hormone therapy, radiotherapy, immunotherapy, other investigational agents or anti-cancer antibody therapy within 28 days prior to arq 197 dose
boolean
cancer surgery
Item
surgery for cancer within 28 days prior to arq 197 dose
boolean
C0920424 (UMLS CUI [1])
Multiple malignancy
Item
active double cancer
boolean
C0346429 (UMLS CUI [1])
brain metastases
Item
known symptomatic brain metastases
boolean
C0220650 (UMLS CUI [1])
intercurrent illness
Item
an intercurrent illness that is uncontrolled (e.g., infection, symptomatic congestive heart failure, unstable angina pectoris, symptomatic arrhythmia, interstitial pneumonia)
boolean
C3640977 (UMLS CUI [1])
pregnant or lactating
Item
pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
contraceptive measures
Item
subjects who wish to have a child and who would not agree to use contraceptive measures
boolean
C0700589 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video